Oramed Pharmaceuticals To Present Oral Insulin Phase 2A Trial Results At The Upcoming Annual Meeting Of The ADA (June 5-9, New Orleans, LA)
Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.
More: continued here
Filed under: Conferences on March 29th, 2009
You must be logged in to post a comment.